Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousTax Patent Legislation: Excusing Infringement of Patented Tax Planning Methods
By Dennis Crouch, Esq.
Rep. Rick Boucher's Bill to excuse infringement of patents covering tax planning methods now has 40 co-sponsors. However, its prospects for becoming law are still slim – only one of the co-sponsors is a member of the House IP Subcommittee which must approve the bill.
The proposal copies the language of the "medical practitioner's performance of a medical activity" exclusion found under 35 USC 287(c). (Known as the Ganske compromise). Under the proposed bill, unauthorized use of a patented tax planning method by a taxpayer or tax practitioner would not be considered infringement.
"With respect to the use by a taxpayer or a tax practitioner of a tax planning method that constitutes an infringement under subsection (a) or (b) of section 271, the provisions of sections 281, 283, 284, and 285 shall not apply against the taxpayer, the tax practitioner, or any related professional organization with respect to such tax planning method."
A tax planning method is defined as any "plan, strategy, technique, or structure that is designed to reduce, minimize, or defer, or has, when implemented, the effect of reducing, minimizing or deferring, a taxpayer's tax liability." The proposal is careful to exclude "tax preparation software or other tools used solely to perform or model mathematical calculations or prepare tax or information returns." This language is potentially too loose — as most tax software does much more than perform math and prepare the return.
Full post as published by Patently Obvious on June 20, 2008 (boomark / email).
Estate Planning
Documents: durable power of attorney, living will, letter of instruction, and insurance trust
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
The Princeton Review
$2.6 million settlement reached in patent infringement case.
Underground Piping
Insituform Technologies awarded $4.5 million patent infringement settlement.
DNA Products
Agilent Technologies pays undisclosed patent infringement settlement to Invitrogen Corporation.

Patent Marking - Court Cautions Against Marking Product if Patent is Expired
IRS Looking at New Taxable Category Based on Patents
Vestcom Files Declaration of no Patent Infringement in Arkansas
New District of Delaware Intellectual Property Case Filings
Patent Exhaustion Doctrine Prevented Pursuit of Customers of a Licensee








